Cervical Cancer Information Center
Each year in the United States, more than 11,000 women are diagnosed with cervical cancer. To reduce this number, researchers continue to explore new approaches to cervical cancer prevention. One very important advance in this area is the development of vaccines against two high-risk types of human papillomavirus (HPV); widespread use of these vaccines could prevent an estimated 70% of all cases of cervical cancer.
Progress is also being made in the early detection and treatment of cervical cancer. Newer approaches to screening include HPV testing and liquid-based Pap testing. Advances in surgery, radiation, and chemotherapy have also made important contributions to improved cervical cancer survival, and it is estimated that there are more than 249,000 cervical cancer survivors in the U.S. today.
Understanding cervical cancer treatment options, the role of different doctors specializing in the treatment of cervical cancer, and how and when to access new and innovative cervical cancer treatment options available through clinical trials is essential in order to achieve the best outcome from cervical cancer treatment.
The Cancer Consultants Cervical Cancer Information Center has been designed to help patients understand options for cervical cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of cervical cancer.
Headline Cervical Cancer News 
Second HPV Vaccine Approved in U.S.
U.S. Food and Drug Administration approves Cervarix® for prevention of cervical cancer and cervical precancers
Number of Obesity-related Cancers Is Growing
Weight responsible for thousands of diagnoses each year
Advisory Committee Backs Second Cervical Cancer Vaccine
Data support Cervarix® safety and efficacy.
Cervical Cancer Tips
For Optimal Care of Gynecologic Cancers, Consult Your Oncologist About Medication Concerns As a patient or caregiver affected by a gynecologic cancer diagnosis...
What Every Woman Should Know About Cancer Screening By Jennifer Maxon, RN Over the past several decades, long-term cancer survival rates...
Who Should Receive the HPV Vaccine? There are 30 to 40 HPV (human papillomavirus) types that infect the genital area....
Cervical Cancer Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Cervical Cancer Clinical Trials
GOG0219 – GOG 0219 A Phase III Randomized Trial of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis
GOG0204 – A Randomized Phase III Trial of Paclitaxel plus Cisplatin versus Vinorelbine plus Cisplatin versus Gemcitabine plus Cisplatin versus Topotecan plus Cisplatin in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
GOG9918 – A Phase I Trial of Tailored Radiation Therapy with Concomitant Cetuximab (C225, NSC #714692) and Cisplatin(NSC #119875) in the Treatment of Patients with Cervical Cancer
 |
 |
 |
 |
